Top

Published in:

01-04-2021 | Coronavirus | Review article

SARS-CoV-2: its potential neurological manifestations and plausible mechanism: a review article

Authors: Tasneem Taher, Anum Bilal Sheikh, Farah Anwar, Faisal Khosa

Published in: Acta Neurologica Belgica | Issue 2/2021

Abstract

Coronavirus disease (COVID-19) was first identified in late December 2019. The disease began in Wuhan, Hubei province in China and since then it has spread quickly to many countries all over the world. COVID-19 is caused by a novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus was majorly seen to overwhelm the respiratory system with mild to severe acute respiratory syndrome considered pathognomic for the disease. However, with time a plethora of symptoms was observed in the patients infected with COVID-19 including strong evidence for neurological symptoms. Evidence suggests that the virus has both central and peripheral nervous system manifestations. Patients, particularly those who suffer from a severe illness, have a central nervous system (CNS) involvement and neurological manifestations. There is precise and targeted documentation of neurological symptoms with details of clinical, neurological, and electrophysiological findings. This review article thus gives an insight into the neuro-invasive potential of COVID-19 and discusses the possible pathogenesis.

Hui DS, Azhar IE, Madani TA, Ntoumi F, Kock R, Dar O, Ippolito G, Mchugh TD, Memish ZA, Drosten C, Zumla A, Petersen E (2020) The continuing 2019 nCoV epidemic threat of novel coronaviruses to global health the latest 2019 novel coronavirus outbreak in Wuhan China. Int J Infect Dis 91(264):266. https://doi.org/10.1016/j.ijid.2020.01.009CrossRef

Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579:270–273. https://doi.org/10.1038/s41586-020-2012-7CrossRefPubMedPubMedCentral

Baig AM, Khaleeq A, Ali U, Syeda H (2020) Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 11(7):995–998. https://doi.org/10.1021/acschemneuro.0c00122CrossRefPubMed

Li YC, Bai WZ, Hashikawa T (2020) The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol 92:552–555. https://doi.org/10.1002/jmv.25728CrossRefPubMed

Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus A first step in understanding SARS pathogenesis. Journal Pathol 203(2):631–637. https://doi.org/10.1002/path.1570CrossRef

Wang HY, Li XL, Yan ZR, Sun XP, Han J, Zhang BW (2020) Potential neurological symptoms of COVID-19. Ther Adv Neurol Disord. https://doi.org/10.1177/1756286420917830CrossRefPubMedPubMedCentral

Mao L, Jin H, Wang M et al (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2020.1127CrossRefPubMedPubMedCentral

Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, Liu C, Yang C (2020) Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. https://doi.org/10.1016/j.bbi.2020.03.031CrossRefPubMedPubMedCentral

Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, Ueno M, Sakata H, Kondo K, Myose N, Nakao A, Takeda M, Haro H, Inoue O, Suzuki-Inoue K, Kubokawa K, Ogihara S, Sasaki T, Kinouchi H, Kojin H, Ito M, Onishi H, Shimizu T, Sasaki Y, Enomoto N, Ishihara H, Furuya S, Yamamoto T, Shimada S (2020) A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. https://doi.org/10.1016/j.ijid.2020.03.062CrossRefPubMedPubMedCentral

10.

Pennisi M, Lanza G, Falzone L, Fisicaro F, Ferri R, Bella R (2020) SARS-CoV-2 and the nervous system: from clinical features to molecular mechanisms. Int J Mol Sci 21(15):5475. https://doi.org/10.3390/ijms21155475CrossRefPubMedCentral

11.

Ye M, Ren Y, Lv T (2020) Encephalitis as a clinical manifestation of COVID-19. Brain Behav Immun. https://doi.org/10.1016/j.bbi.2020.04.017CrossRefPubMedPubMedCentral

12.

Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B (2020) COVID-19–associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology. https://doi.org/10.1148/radiol.2020201187CrossRefPubMed

13.

Filatov A, Sharma P, Hindi F, Espinosa PS (2020) Neurological complications of Coronavirus disease (COVID-19): encephalopathy. Cureus 12(3):e7352. https://doi.org/10.7759/cureus.7352CrossRefPubMedPubMedCentral

14.

Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, Collange O, Boulay C, Fafi-Kremer S, Ohana M, Anheim M, Meziani F (2020) Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. https://doi.org/10.1056/nejmc2008597CrossRefPubMedPubMedCentral

15.

Sharifian-Dorche M, Huot P, Osherov M, Wen D, Saveriano A, Giacomini PS, Antel JP, Mowla A (2020) Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic. J Neurol Sci. https://doi.org/10.1016/j.jns.2020.117085CrossRefPubMedPubMedCentral

16.

Sharifi-Razavi A, Karimi N, Rouhani N (2020) COVID-19 and intracerebral haemorrhage: causative or coincidental? New Microbes New Infect. https://doi.org/10.1016/j.nmni.2020.100669CrossRefPubMedPubMedCentral

17.

Battaglini D, Brunetti I, Anania P et al (2020) Neurological Manifestations of Severe SARS-CoV-2 infection: potential mechanisms and implications of individualized mechanical ventilation settings. Front Neurol 11:845. https://doi.org/10.3389/fneur.2020.00845CrossRefPubMedPubMedCentral

18.

Chen Z, Fu J, Shu Q, Chen Y, Hua C, Li F, Lin R, Tang L, Wang T, Wang W, Wang Y, Xu W, Yang Z, Ye S, Yuan T, Zhang C, Zhang Y (2020) Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World J Pediatr. https://doi.org/10.1007/s12519-020-00345-5CrossRefPubMedPubMedCentral

19.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323(11):1061–1069. https://doi.org/10.1001/jama.2020.1585CrossRefPubMedPubMedCentral

20.

Zhai P, Ding Y, Li Y (2020) The impact of COVID-19 on ischemic stroke: a case report. Diagn Pathol 15:78. https://doi.org/10.1186/s13000-020-00994-0CrossRefPubMedPubMedCentral

21.

Oxley TJ, Mocco J, Majidi S et al (2020) Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med 382:e60. https://doi.org/10.1056/NEJMc2009787CrossRefPubMed

22.

Mehta P, McAuley D, Brown M, Sanchez E, Tattersall R, Manson J (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395(10229):1033–1034. https://doi.org/10.1016/s0140-6736(20)30628-0CrossRefPubMedPubMedCentral

23.

Bertran Recasens B, Martinez-Llorens JM, Rodriguez-Sevilla JJ, Rubio MA (2020) Lack of dyspnea in Covid-19 patients; another neurological conundrum? Eur J Neurol. https://doi.org/10.1111/ene.14265CrossRefPubMedPubMedCentral

24.

Turtle L (2020) Respiratory failure alone does not suggest central nervous system invasion by SARS-CoV-2. J Med Virol. https://doi.org/10.1002/jmv.25828CrossRefPubMedPubMedCentral

25.

Zhao H, Shen D, Zhou H, Liu J, Chen S (2020) Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol 19(5):383–384. https://doi.org/10.1016/s1474-4422(20)30109-5CrossRefPubMedPubMedCentral

26.

Gutiérrez-Ortiz C, Méndez A, Rodrigo-Rey S, San Pedro-Murillo E, Bermejo-Guerrero L, Gordo-Mañas R, de Aragón-Gómez F, Benito-León J (2020) Miller fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. https://doi.org/10.1212/wnl.0000000000009619CrossRefPubMed

27.

Ahmad I, Rathore FA (2020) Neurological manifestations and complications of COVID-19: a literature review. J Clin Neurosci. https://doi.org/10.1016/j.jocn.2020.05.017CrossRefPubMedPubMedCentral

28.

Karimi N, Sharifi Razavi A, Rouhani N (2020) Frequent convulsive seizures in an adult patient with COVID-19: a case report. Iran Red Crescent Med J. https://doi.org/10.5812/ircmj.102828CrossRef

29.

Lau SK, Woo PC, Yip CC et al (2006) Coronavirus HKU1 and other coronavirus infections in Hong Kong. J Clin Microbiol. https://doi.org/10.1128/JCM.02614-05CrossRefPubMedPubMedCentral

30.

Li Y, Li H, Fan R et al (2016) Coronavirus infections in the central nervous system and respiratory tract show distinct features in hospitalized children. Intervirology. https://doi.org/10.1159/000453066CrossRefPubMed

31.

Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S (2020) Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2020.2065CrossRefPubMedPubMedCentral

32.

Campiglio L, Priori A (2020) Neurological symptoms in acute COVID-19 infected patients: a survey among Italian physicians. PLoS ONE. https://doi.org/10.1371/journal.pone.0238159CrossRefPubMedPubMedCentral

33.

Liu K, Pan M, Xiao Z, Xu X (2020) Neurological manifestations of the coronavirus (SARS-CoV-2) pandemic 2019–2020. J Neurol Neurosurg Psychiatry. https://doi.org/10.1136/jnnp-2020-323177CrossRefPubMed

34.

Gupta N, Agrawal S, Ish P et al (2020) Clinical and epidemiologic profile of the initial COVID-19 patients at a tertiary care centre in India. Monaldi Arch Chest Dis. https://doi.org/10.4081/monaldi.2020.1294CrossRefPubMed

35.

Borges do Nascimento IJ, Cacic N, Abdulazeem HM et al (2020) Novel coronavirus infection (COVID-19) in humans: a scoping review and meta-analysis. J Clin Med. https://doi.org/10.3390/jcm9040941CrossRefPubMedPubMedCentral

36.

Steardo L, Zorec R, Verkhratsky A (2020) Neuro infection may contribute to pathophysiology and clinical manifestations of COVID-19. Acta Physiol. https://doi.org/10.1111/apha.13473CrossRef

37.

Wu P, Duan F, Luo C, Liu Q, Qu X, Liang L, Wu K (2020) Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. https://doi.org/10.1001/jamaophthalmol.2020.1291CrossRefPubMedPubMedCentral

38.

Nathan N, Prevost B, Corvol H (2020) Atypical presentation of COVID-19 in young infants. Lancet 395(10235):1481. https://doi.org/10.1016/S0140-6736(20)30980-6CrossRefPubMedPubMedCentral

39.

Wei H, Yin H, Huang M, Guo Z (2020) The 2019 novel coronavirus pneumonia with onset of oculomotor nerve palsy: a case study. J Neurol 267(5):1550–1553. https://doi.org/10.1007/s00415-020-09773-9CrossRefPubMed

40.

Dinkin M, Gao V, Kahan J, Bobker S, Simonetto M, Wechsler P et al (2020) COVID-19 presenting with ophthalmoparesis from cranial nerve palsy. Neurology 95(5):221–223. https://doi.org/10.1212/wnl.0000000000009700CrossRefPubMed

41.

Keyhan SO, Fallahi HR, Cheshmi B (2020) Dysosmia and dysgeusia due to the 2019 novel coronavirus; a hypothesis that needs further investigation. Maxillofacial plastic and reconstructive surgery 42(1):9. https://doi.org/10.1186/s40902-020-00254-7CrossRefPubMedPubMedCentral

42.

Mehraeen E, Behnezhad F, Salehi MA, Noori T, Harandi H, SeyedAlinaghi S (2020) Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID-19): a review of current evidence. Eur Arch Otorhinolaryngol. https://doi.org/10.1007/s00405-020-06120-6CrossRefPubMedPubMedCentral

43.

Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S (2008) Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol 82(15):7264–7275. https://doi.org/10.1128/JVI.00737-08CrossRefPubMedPubMedCentral

44.

Zhang YH, Hao QQ, Wang XY, Chen X, Wang N, Zhu L, Li SY, Yu QT, Dong B (2015) ACE2 activity was increased in atherosclerotic plaque by losartan: possible relation to anti-atherosclerosis. J Renin Angiotensin Aldosterone Syst 16(2):292–300. https://doi.org/10.1177/1470320314542829CrossRefPubMed

45.

Jin H, Hong C, Chen S, Zhou Y, Wang Y, Mao L, Li Y, He Q, Li M, Su Y, Wang D, Wang L, Hu B (2020) Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists. Stroke Vasc Neurol. https://doi.org/10.1136/svn-2020-000382CrossRefPubMedPubMedCentral

46.

Barrantes FJ (2020) Central nervous system targets and routes for SARS-CoV-2: current views and new hypotheses. ACS Chem Neurosci. https://doi.org/10.1021/acschemneuro.0c00434CrossRefPubMed

47.

Brann DH, Tsukahara T, Weinreb C, Lipovsek M, Van den Berge K, Gong B, Chance R, Macaulay I, Chou H, Fletcher R, Das D, Street K, de Bezieux HR, Choi Y, Risso D, Dudoit S, Purdom E, Mill JS, Hachem RA, Matsunami H, Logan D, Goldstein B, Grubb MS, Ngai J, Datta SR (2020) Non-neuronal expression of SARS-Cov-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. BioRxiv. https://doi.org/10.1101/2020.03.25.009084CrossRef

48.

Perlman S, Evans G, Afifi A (1990) Effect of olfactory bulb ablation on spread of a neurotropic coronavirus into the mouse brain. J Exp Med 172(4):1127–1132. https://doi.org/10.1084/jem.172.4.1127CrossRefPubMed

49.

Bohmwald K, Gálvez NMS, Ríos M, Kalergis AM (2018) Neurologic alterations due to respiratory virus infections. Front Cell Neurosci 12:386. https://doi.org/10.3389/fncel.2018.00386CrossRefPubMedPubMedCentral

50.

Esposito G, Pesce M, Seguella L, Sanseverino W, Lu J, Sarnelli G (2020) Can the enteric nervous system be an alternative entrance door in SARS-CoV2 neuroinvasion? Brain Behav Immun 87:93–94. https://doi.org/10.1016/j.bbi.2020.04.060CrossRefPubMedPubMedCentral

51.

Luo P, Liu Y, Qiu L, Liu X, Liu D, Li J (2020) Tocilizumab treatment in COVID-19: a single center experience. J Med Virol. https://doi.org/10.1002/jmv.25801CrossRefPubMedPubMedCentral

52.

Niaura R, Poulas K, Kouretas D, Barbouni A, Tsatsakis A, Farsalinos K, Vantarakis A, Houezec L (2020) Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system. Toxicology Rep 7:658–663. https://doi.org/10.1016/j.toxrep.2020.04.012CrossRef

Title: SARS-CoV-2: its potential neurological manifestations and plausible mechanism: a review article
Authors: Tasneem Taher
Anum Bilal Sheikh
Farah Anwar
Faisal Khosa
Publication date: 01-04-2021
Publisher: Springer International Publishing
Keywords: Coronavirus
SARS-CoV-2
COVID-19
Published in: Acta Neurologica Belgica / Issue 2/2021
Print ISSN: 0300-9009
Electronic ISSN: 2240-2993
DOI: https://doi.org/10.1007/s13760-020-01577-y

At a glance: The STEP trials

Springer Medicine

SARS-CoV-2: its potential neurological manifestations and plausible mechanism: a review article

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2021

The relationship between motor performance and femoral cartilage thickness in children with Down syndrome

Spontaneous rupture of cerebral aneurysm after thrombectomy in a case of acute ischemic stroke with proximal occlusion

A rare case of parasagittal meningioma causing isolated foot drop: case report and review of the literature

Dilated pupils in an anxious patient

Another brick in the wall: is hexane neuropathy a ‘nodo-paranodopathy’?

Effects of resveratrol in the signaling of neuropathic pain involving P2X3 in the dorsal root ganglion of rats